This is likely due to the limited number of patients available with followed-up information and the lack of sufficient number of patients with RKIP-positive ccRCC, as a result of a common RKIP reduction, adds an additional challenge. The gene discussed is PEBP1; the disease is nonpapillary renal cell carcinoma.